Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

GAIA

Financiado

Cerrado

Graphene-based Artificial Iris for Active light management in a smart contact le...

Graphene-based Artificial Iris for Active light management in a smart contact lens Smart contact lenses have the potential to address multiple medical unmet needs, such as vision correction, diagnosis of eye disorders and monitoring of biomarkers. For instance, liquid crystal (LC) cells controlled by smart elect... ver más

28/02/2027

AZALEA VISION

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

AZALEA VISION No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-03-01

HORIZON-EIC-2023-TRANSITIONCHALLENGES-01: EIC Transition Challenge: Full scal... Scope:The scope of the Challenge is the maturation of Micro-Nano-Bio technologies developed in previ...

I+D

Cerrada hace 1 año

0% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

AZALEA VISION

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 35 meses Fecha Inicio: 2024-03-01
Fecha Fin: 2027-02-28

Líder del proyecto

AZALEA VISION No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Smart contact lenses have the potential to address multiple medical unmet needs, such as vision correction, diagnosis of eye disorders and monitoring of biomarkers. For instance, liquid crystal (LC) cells controlled by smart electronics and embedded inside contact lenses can autonomously control light intensity and visual acuity for patients suffering iris disorders. However, a couple of technological challenges remain unresolved before patient validation. The properties of LC cells are not optimal when using standard materials such as PEDOT:PSS and ITO. The former reduces the transmittance while the sheet resistance of the latter is greatly affected by thermoforming steps. In addition, LC ionic currents need to be reduced to favour power consumption. The GAIA project will address these limitations by introducing a graphene-based artificial iris. The unique combination of properties of graphene, i.e., mechanical robustness, high transmittance and lower ionic introduction, make it an ideal material for eye-related smart applications.We will combine the artificial iris management technology based on LC cells already developed by Azalea with the graphene microfabrication techniques developed by ICN2 to deliver medical optical systems with ultra-low power consumption, and unprecedented transparency and flexibility. The graphene artificial iris will autonomously change the size of the pupil to control the depth of field, visual acuity and improve the quality of life of millions of people. Our consortium brings together all the key expertise to achieve the project goals. Azalea is an SME with expertise in active light management, stretchable electronics and electronics integration in contact lenses, while ICN2 is a top academic research centre with unique knowledge in flexible graphene electrodes fabrication. Together, we will develop and validate the next generation of smart contact lenses to bring a revolutionary product to the market to solve unmet medical needs.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores